News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
563,750 Results
Type
Article (45512)
Company Profile (121)
Press Release (518117)
Section
Business (155346)
Career Advice (2409)
Deals (29027)
Drug Delivery (119)
Drug Development (71255)
Employer Resources (151)
FDA (15817)
Job Trends (12464)
News (278791)
Policy (30509)
Tag
2024 BioCapital Digital (5)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (9)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (4)
2024 Genetown Standard (5)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (4)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2363)
Academic (1)
Accelerated approval (5)
Adcomms (29)
Allergies (76)
Alliances (36951)
ALS (84)
Alzheimer's disease (1434)
Antibody-drug conjugate (ADC) (129)
Approvals (15774)
Artificial intelligence (226)
Autoimmune disease (21)
Automation (10)
Bankruptcy (317)
Best Places to Work (9663)
BIOSECURE Act (21)
Biosimilars (110)
Biotechnology (72)
Bladder cancer (61)
Brain cancer (25)
Breast cancer (247)
Cancer (1951)
Cardiovascular disease (177)
Career advice (2011)
Career pathing (32)
CAR-T (137)
Cell therapy (396)
Cervical cancer (20)
Clinical research (57744)
Collaboration (675)
Compensation (467)
Complete response letters (29)
COVID-19 (2636)
CRISPR (40)
C-suite (199)
Cystic fibrosis (95)
Data (1875)
Decentralized trials (2)
Denatured (14)
Depression (49)
Diabetes (252)
Diagnostics (5462)
Digital health (14)
Diversity (4)
Diversity, equity & inclusion (42)
Drug discovery (95)
Drug pricing (118)
Drug shortages (30)
Duchenne muscular dystrophy (89)
Earnings (65998)
Editorial (40)
Employer branding (20)
Employer resources (136)
Events (91151)
Executive appointments (593)
FDA (16927)
Featured Employer (33)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (604)
Gene editing (100)
Generative AI (21)
Gene therapy (296)
GLP-1 (773)
Government (4109)
Grass and pollen (5)
Guidances (46)
Healthcare (15608)
Huntington's disease (23)
IgA nephropathy (26)
Immunology and inflammation (127)
Indications (23)
Infectious disease (2771)
Inflammatory bowel disease (129)
Inflation Reduction Act (9)
Influenza (46)
Intellectual property (82)
Interviews (450)
IPO (14546)
IRA (48)
Job creations (3198)
Job search strategy (1672)
Kidney cancer (10)
Labor market (28)
Layoffs (500)
Leadership (20)
Legal (7174)
Liver cancer (68)
Lung cancer (283)
Lymphoma (133)
Machine learning (4)
Management (51)
Manufacturing (260)
MASH (65)
Medical device (11557)
Medtech (11560)
Mergers & acquisitions (14935)
Metabolic disorders (684)
Multiple sclerosis (73)
NASH (22)
Neurodegenerative disease (91)
Neuropsychiatric disorders (31)
Neuroscience (1931)
NextGen: Class of 2025 (5205)
Non-profit (3371)
Northern California (2319)
Now hiring (16)
Obesity (380)
Opinion (219)
Ovarian cancer (66)
Pain (80)
Pancreatic cancer (72)
Parkinson's disease (139)
Partnered (15)
Patents (206)
Patient recruitment (88)
Peanut (45)
People (44067)
Pharmaceutical (36)
Pharmacy benefit managers (21)
Phase I (17126)
Phase II (25100)
Phase III (20451)
Pipeline (1063)
Podcasts (77)
Policy (137)
Postmarket research (2377)
Preclinical (7056)
Press Release (37)
Prostate cancer (96)
Psychedelics (36)
Radiopharmaceuticals (220)
Rare diseases (378)
Real estate (4404)
Recruiting (60)
Regulatory (21282)
Reports (32)
Research institute (2099)
Resumes & cover letters (402)
Rett syndrome (4)
RNA editing (3)
RSV (44)
Schizophrenia (72)
Series A (115)
Series B (74)
Service/supplier (10)
Sickle cell disease (53)
Southern California (1977)
Special edition (16)
Spinal muscular atrophy (132)
Sponsored (32)
Startups (2820)
State (1)
Stomach cancer (16)
Supply chain (64)
Tariffs (14)
The Weekly (62)
United States (19569)
Vaccines (735)
Venture capitalists (38)
Webinars (11)
Weight loss (283)
Women's health (31)
Worklife (19)
Date
Last 7 days (628)
Last 30 days (2321)
Last 365 days (30890)
2025 (7940)
2024 (32369)
2023 (36360)
2022 (46518)
2021 (50204)
2020 (47189)
2019 (38128)
2018 (28868)
2017 (28814)
2016 (27344)
2015 (30613)
2014 (24111)
2013 (19571)
2012 (21040)
2011 (21511)
2010 (19456)
Location
Africa (682)
Alabama (43)
Alaska (6)
Arizona (174)
Arkansas (10)
Asia (32301)
Australia (5651)
California (5192)
Canada (1499)
China (399)
Colorado (226)
Connecticut (254)
Delaware (120)
Europe (78250)
Florida (770)
Georgia (179)
Hawaii (1)
Idaho (39)
Illinois (429)
India (22)
Indiana (247)
Iowa (9)
Japan (133)
Kansas (82)
Kentucky (13)
Louisiana (6)
Maine (61)
Maryland (801)
Massachusetts (3929)
Michigan (178)
Minnesota (325)
Mississippi (1)
Missouri (69)
Montana (12)
Nebraska (19)
Nevada (50)
New Hampshire (52)
New Jersey (1496)
New Mexico (15)
New York (1467)
North Carolina (878)
North Dakota (6)
Northern California (2319)
Ohio (153)
Oklahoma (8)
Oregon (28)
Pennsylvania (1138)
Puerto Rico (9)
Rhode Island (17)
South America (1046)
South Carolina (16)
South Dakota (1)
Southern California (1977)
Tennessee (82)
Texas (730)
Utah (144)
Virginia (118)
Washington D.C. (56)
Washington State (481)
West Virginia (3)
Wisconsin (48)
563,750 Results for "philogen s p a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Philogen enters into a Service and Supply Agreement with IBSA for the GMP Production of a Therapeutic Protein
Philogen S.p.A announced that it has entered into a Service and Supply Agreement with IBSA to produce a recombinant therapeutic protein at Philogen GMP Facilities in Siena.
June 28, 2023
·
4 min read
Philogen Announces Clinical Trial Collaboration with MSD
Philogen S.p.A. announces that it has entered into a Clinical Trial Collaboration and Supply Agreement with MSD.
June 1, 2023
·
3 min read
Business
Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand
Sun Pharmaceutical Industries Limited and Philogen S.p.A announced that they have entered into a licensing agreement for commercializing Philogen’s specialty product, Nidlegy™ in the territories of Europe, Australia and New Zealand.
May 30, 2023
·
5 min read
Philogen Publishes New Data on a Fibromun-based treatment combination in Science Translational Medicine in collaboration with the University Hospital Zürich
Philogen S.p.A. announces the publication of the latest results of Fibromun in combination with lomustine for the treatment of glioblastoma in Science Translational Medicine describing how the combination treatment cured orthotopic glioma-bearing mice and mediated durable objective responses and major tumor shrinkage in patients with recurrent glioblastoma.
May 25, 2023
·
10 min read
Press Releases
David P. King Joins Truvian’s Advisory Board
January 13, 2025
·
2 min read
Press Releases
Acadia Pharmaceuticals Set to Join S&P SmallCap 600
December 31, 2024
·
1 min read
Philogen to Present at UBS Global Healthcare Conference
Philogen S.p.A. today announces that it will present at the UBS Global Healthcare Conference on May 25, 2022 at the Lotte New York Palace.
May 5, 2022
·
2 min read
Philogen Provides Corporate Update - June 23, 2022
Philogen S.p.A., a clinical-stage biotechnology company focused on antibody- and small molecule-based targeted therapeutics, provides an update regarding recent corporate developments.
June 23, 2022
·
6 min read
Press Releases
Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A
January 14, 2025
·
4 min read
Philogen announces publication in Chem (Cell Press) on novel affinity matured OncoFAP ligands isolated from DNA-Encoded Chemical Libraries
Philogen S.p.A., a clinical-stage biotechnology company focused on the development of innovative medicines based on tumor targeting antibodies and small molecule ligands, announces the publication of a study in the peer-reviewed journal “Chem” describing the design, development and the in vivo characterization of novel OncoFAP ligands.
November 7, 2022
·
3 min read
1 of 56,375
Next
